19-53068279-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001322131.2(ZNF160):c.2255G>A(p.Arg752Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,613,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001322131.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF160 | NM_001322131.2 | c.2255G>A | p.Arg752Gln | missense_variant | 6/6 | ENST00000683776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF160 | ENST00000683776.1 | c.2255G>A | p.Arg752Gln | missense_variant | 6/6 | NM_001322131.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152038Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251132Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135728
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461702Hom.: 0 Cov.: 32 AF XY: 0.0000426 AC XY: 31AN XY: 727158
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152038Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.2255G>A (p.R752Q) alteration is located in exon 7 (coding exon 4) of the ZNF160 gene. This alteration results from a G to A substitution at nucleotide position 2255, causing the arginine (R) at amino acid position 752 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at